Loop 1 of APOBEC3C Regulates its Antiviral Activity against HIV-1
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 432 (23) , 6200-6227
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Heinrich-Heine-University Düsseldorf (2019-13)
- German Academic Exchange Service
- China Scholarship Council
- German Ministry of Health (G115F020001)
- Heinz-Ansmann Foundation for AIDS Research
- Deutsche Forschungsgemeinschaft (417919780, INST 208/761-1 FUGG)
This publication has 121 references indexed in Scilit:
- An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancersNature Genetics, 2013
- APOBEC3B is an enzymatic source of mutation in breast cancerNature, 2013
- MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and UsabilityMolecular Biology and Evolution, 2013
- Model structure of APOBEC3C reveals a binding pocket modulating ribonucleic acid interaction required for encapsidationProceedings of the National Academy of Sciences, 2009
- Species-specific Inhibition of APOBEC3C by the Prototype Foamy Virus Protein BetJournal of Biological Chemistry, 2009
- Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3GNucleic Acids Research, 2007
- Cytidine Deamination of Retroviral DNA by Diverse APOBEC ProteinsCurrent Biology, 2004
- Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcriptsNature, 2003
- Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif proteinNature, 2002
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983